Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Other Operating Expenses: 2010-2025

Historic Other Operating Expenses for Lifecore Biomedical (LFCR) over the last 1 years, with May 2025 value amounting to -$1.1 million.

  • Lifecore Biomedical's Other Operating Expenses rose 54.54% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was $409,000, marking a year-over-year decrease of 98.96%. This contributed to the annual value of $409,000 for FY2025, which is 98.96% down from last year.
  • Lifecore Biomedical's Other Operating Expenses amounted to -$1.1 million in Q2 2025, which was down 81.83% from -$600,000 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Other Operating Expenses registered a high of $21.0 million during Q1 2024, and its lowest value of -$2.4 million during Q2 2024.
  • For the 3-year period, Lifecore Biomedical's Other Operating Expenses averaged around $5.0 million, with its median value being $550,000 (2023).
  • Per our database at Business Quant, Lifecore Biomedical's Other Operating Expenses surged by 350.00% in 2024 and then plummeted by 102.86% in 2025.
  • Quarterly analysis of 4 years shows Lifecore Biomedical's Other Operating Expenses stood at $2.1 million in 2022, then tumbled by 90.51% to $20.7 million in 2023, then plummeted by 94.20% to $1.2 million in 2024, then surged by 54.54% to -$1.1 million in 2025.
  • Its Other Operating Expenses stands at -$1.1 million for Q2 2025, versus -$600,000 for Q1 2025 and $1.2 million for Q4 2024.